US Drug Supply Chain Security Act - Connie Jung, RPh, PhD, Senior Advisor for Policy, Office of Drug Security, Integrity, and Response (ODSIR), Center for Drug Evaluation and Research, Office of Compliance, US FDA, US
Pharmaceutical traceability – the public pharmacy perspective - Maayke Fluitman, PharmD, CEO, Care2create, the Netherlands
Breakout Sessions
Panel – GDSN to support regulation and trading partner collaboration - Nazly Chacon, Director of Technological Support, Coopidrogas, Colombia; MJ Wylie, Global GDSN Strategy & Deployment, Johnson & Johnson, US; Tony Scanio, Director Data Management and Business Intelligence, Christus Health, US; Stéphane Ancel, CEO, GAM, France
Panel – Pharmaceutical serialisation and traceability - Scott Mooney, Vice President Distribution Operations, McKesson, US; Carole Laloum, Serialisation Distribution Manager Supply Chain, Servier, France; Stefan Artlich, Director 'Track&Trace', Bayer, Germany; Senthil Rajaratnam, Affiliate Serialisation Account Manager, Eli Lilly and Company, US
Panel – RFID vs data matrix for pharma traceability - Grant Courtney, Manager, Falsified Medicines Directive Project, GSK, US; Pascal Aulagnet, Senior Manager, Global Serialisation - EMEA Client Partner, Pfizer, France; Sébastien Langlois-Berthelot, Project Manager, Roche, Switzerland; Camilo Higuita - IT & Innovation Manager, Crystal SAS, Colombia
